Skip to main content
. 2021 May 26;10(6):1320. doi: 10.3390/cells10061320
ATMP Advanced therapeutic medicinal product
BM Bone marrow
CBT Cord blood transplantation
DMSO Dimethyl sulfoxide
DT Doubling time
EBMT European Group for Blood and Marrow Transplantation
EP European pharmacopeia
FBS Fetal bovine serum
FDA Food and drug administration
FIFO First-in first-out
GMP Good manufacturing practice
GVHD Graft versus host disease
HCT Hematopoietic cell transplantation
HPL Human platelet lysate
HSA Human serum albumin
IDO Indolamine oxidase
IFNγ Interferon gamma
ISBT International society of blood transfusion
ISCT International Society of Cellular Therapy
IQ Installation qualification
IV Intravenous
LTCG Laboratory of Cell and Gene Therapy
MLR Mixed Lymphocyte Reaction
MSC Mesenchymal stem/stromal cells
NaCl Sodium chloride
NAT Nucleic amplification technique
OQ Operational qualification
PBMC Peripheral blood mononuclear cells
PDL Population doubling level
PDL-1 Programmed death ligand 1
PQ Performance qualification
QA Quality assurance
QC Quality control
QP Qualified person
SCM Serum-containing media
SFM Serum-free media
SOP Standard operating procedure
TSE Transmission of spongiform encephalopathy
URS User-specific specifications